MET and uterine corpus sarcoma: Interestingly, the growth of tumour xenografts formed by ABCB1/MDR1-overexpressed MDR uterine sarcoma and breast cancer cell lines, knocked down for MET with shRNA, was reduced compared to tumours formed by control shRNA transfected cells [33].